Strategy for rational combinations of therapeutics to target resistant human myeloma cell lines. Collaborative Agreement Celgene and Prof Andrew Spencer and Dr Tiffany Khong.

Project: Research

StatusActive
Effective start/end date2/10/1931/12/24

Keywords

  • Malignant Haematology